Dr. Thomas Brenn is a distinguished expert in dermatopathology. Graduating magna cum laude from the Ruprecht-Karls University of Heidelberg, Germany, he earned both his MD and PhD degrees. Following postdoctoral fellowships at Stanford University and residency training at Brigham and Women’s Hospital, he pursued subspecialty fellowships in dermatopathology, soft tissue tumor pathology, and surgical pathology.
In 2003, Dr. Brenn joined the faculty of Brigham and Women’s Hospital and Harvard Medical School. He later served as the Head of Dermatopathology at the University of Edinburgh, Scotland from 2007 to 2018. Currently, he holds the position of Professor of Pathology & Laboratory Medicine at the Cumming School of Medicine, University of Calgary since 2018.
Dr. Brenn’s clinical and research interests revolve around cutaneous mesenchymal, adnexal, and melanocytic tumor pathology. He has made significant contributions to the field and holds prestigious roles such as Associate Editor for Histopathology and membership in the Consensus Group for the 4th and Expert Editor Panel for the 5th editions of the WHO Classification of Skin Tumors. Additionally, he serves as the editor of the current Series 5 AFIP Atlas of Tumor Pathology on Non-melanocytic Tumors of the Skin and has co-edited the 4th and 5th editions of McKee’s Pathology of the Skin.
Dr. Thomas Brenn’s expertise and leadership have profoundly influenced the field of dermatopathology, making him a highly respected figure in the medical community.
